IL2 and neoplasm: Programmed death ligand 1 on the cell surface facilitates tumor immune escape by inducing activated T cell apoptosis, promoting T cell weakness, enhancing the function of regulatory T (Treg) cells, inhibiting T cell proliferation, activating damaged T cells, and stimulating the production of IL-2 (Zhang et al., 2015; Sun et al., 2018).